Investing in a world where preventable second strokes no longer occur.
METIS provided Precision Recovery with the first seed investment to go about building the PRI product and brand.
METIS's knowledge of neurology and stroke has helped PRI shape their product and go-to-market strategy. Our network of operators and healthcare professionals working in neurology and stroke helped PRI identify the first wave of hospital partners outside of Mount Sinai Hospital.
Stroke is the leading cause of disability in the US and is growing in incidence. 50% of patients readmit to hospital in the first year after stroke and yet up to 70% of stroke readmissions are potentially preventable. By deploying a tailored post-stroke virtual care program, hospitals can improve the quality of care they provide and reduce readmission.
PRISM by Precision Recovery is America's first virtual care program dedicated exclusively to stroke survivors. It was developed by neurology experts at Mount Sinai hospital in New York City, one of the worlds leading stroke centers. Many thousands of patients have benefitted from the service, which helps to identify the early signs of stroke recurrence and allows earlier intervention.
PRI has an unprecedented opportunity to transform the face of care for stroke survivors once they leave the hospital. As PRI continues to scale and develop their product, they work towards the opportunity for every stroke survivor in the country to have some level of access to their product.
PRI aims to partner with 300 hospitals over the next 5 years and enroll up to 90,000 patients onto their PRISM program. They are working with some of the leading stroke centers and medical directors in the country to demonstrate, through peer reviewed publication, the impact of PRISM in hospital readmission reduction.
